Mannatech Review (2026): Is Mannatech Still in Business, and Is It Worth Joining?

If someone has told you about Ambrotose or "glyconutrients," you've met Mannatech. It's a Texas supplement company that has sold through independent Associates since the 1990s, and it's one of the few network marketing companies that's publicly traded.

That last part matters, because it means Mannatech has to file its numbers with the SEC. This Mannatech review uses those filings, its own income disclosure, and its product pages to answer the questions people actually search: is it still in business, is it worth joining, and what does it cost.

Quick answer: Mannatech is still operating in 2026. It sells supplements like Ambrotose ($159.99), lets Associates join for $49.99, and reported $108.0 million in 2025 sales. Its 2025 US income disclosure says 15,773 Associates earned no commissions or bonuses that year, and its latest quarterly report says there is "substantial doubt" about its ability to continue as a going concern.

I've been inside 8 network marketing companies since 2004, and I always start with the company's own words. For this review I read Mannatech's US site, its 2025 Income Disclosure Statement and Career and Compensation Plan, its 2025 annual report and 2026 SEC filings, its 2008 and 2009 legal disclosures, and the FDA's 2017 warning letter. You can browse every company I've reviewed on one page.

Here's what I found.

Is Mannatech Still in Business?

Yes. When I checked usa.mannatech.com on October 14, 2026, it carried "© 2026 Mannatech" and a "FREE SHIPPING ON ALL SUBSCRIPTION ORDERS OVER $224.99!" offer.

The financial picture is tighter. Mannatech's quarterly report for the period ended June 30, 2026, says:

• Net sales were $26.7 million for the quarter, up 3.8% from a year earlier.
• Net income was $1.0 million for the quarter and $2.0 million for the six months. The report says $4.9 million of the six-month improvement came from foreign currency swings (a $1.7 million gain, after a $3.2 million loss a year earlier), and that the company "does not expect this favorable effect to necessarily recur."
• Cash was $6.0 million.
• Total liabilities ($32.4 million) were higher than total assets ($27.5 million), a shareholders' deficit of about $5.0 million.

The same report says these conditions "have raised substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued." That's the company's own disclosure, and it's the most important sentence in this review if you're thinking about building a business there.

For a longer view, 2025 net sales were $108.0 million, down from $117.9 million in 2024, and active associate and preferred customer positions fell from about 133,000 to about 114,000.

You can compare Mannatech's status with other companies in the full MLM company directory.

The Nasdaq Notice

On April 24, 2026, Mannatech disclosed that Nasdaq had told it, in an April 20 letter, it was "not in compliance" with a listing rule requiring "minimum stockholders' equity of $2,500,000." On October 14, 2026, it filed a report saying it "believes" it "has regained compliance," on a pro forma basis, while adding, "There can be no assurance that Nasdaq will concur."

So as of the day I checked, that's the company's own view, not Nasdaq's confirmation.

What Is Mannatech?

Who's Behind Mannatech?

Samuel Caster founded the company in 1993, according to Wikipedia. Today its President and CEO is Landen Fredrick, who has held the role "since April 1, 2024," according to the company's annual report, which also describes him as the son of J. Stanley Fredrick.

J. Stanley Fredrick retired as board chairman effective September 1, 2026, and the board named Robert Toth chairman. In June 2026, the company appointed Yasir Haider as chief financial officer.

What Mannatech Sells and What It Costs

Here are prices from usa.mannatech.com on October 14, 2026:

Ambrotose is the flagship. Mannatech calls Ambrotose Complex "the original Glycan supplement." I'm not going to make health claims for it. What I can tell you is that the FDA objected to the term in 2017, saying "'glyconutrient' does not appear to be a meaningful term that consumers would understand." Talk to your doctor before starting any supplement.

How the Mannatech Compensation Plan Works

Joining is cheap. The 2025 income disclosure says, "In 2025, the cost to sign up as an Associate was $49.99. For 2026, the cost will remain at $49.99," and that you're "not required to purchase products when you enroll." The yearly renewal fee was also $49.99 in 2025.

The Career and Compensation Plan lists "6 WAYS TO EARN":

1. First Order Bonus
2. Customer Bonuses
3. Mentor Bonus
4. Uni-Level Payouts / Infinity Bonus
5. Leader Check Match
6. Global Pool Bonus

The plan says "Approximately 41.1% of the funds Mannatech receives for all products sold are paid as bonuses." Ranks require "150 PPV" in personal purchase volume, and "Associates must renew their accounts annually."

What Mannatech Associates Actually Earn

This is where I'd slow down. Mannatech's 2025 US Income Disclosure Statement says:

• "As of December 31, 2025, Mannatech had a total of 17,989 Associates in the United States."
• "There were 15,773 Associates who did not earn commissions or bonuses in 2025."
• "There were 718 new Associates who joined Mannatech in 2025."

One honest note: the sentence between the first two reads "Of that 17,257," a number that doesn't match the 17,989 total, so I'm quoting both as printed rather than calculating a percentage the company didn't state. Either way, most US Associates earned nothing from the company in 2025.

To Mannatech's credit, it publishes this, and the join page says plainly that it "does not guarantee the amount of income or incentive rewards, if any."

What Regulators and Courts Have Said

People search "Mannatech lawsuit," so here's the record from the primary documents. None of these is recent, and the company has stayed in business throughout.

• Securities class action, 2008. Mannatech disclosed that "Without admitting any liability or wrongdoing of any kind, the Company has agreed to authorize payment to the plaintiff class of $11.25 million," funded by its insurer and the company.
• Texas Attorney General, 2009. The company said it "will pay $6 million, of which $4 million is designated for restitution to consumers and $2 million is designated to cover fees and expenses of Texas regulators," and that "The settlement does not include any fine or penalty." Its release also said the Attorney General reached a separate settlement with founder Sam Caster that "includes a fine of $1 million."
• FDA warning letter, November 14, 2017. The FDA cited manufacturing-practice violations, said its BounceBack product was being marketed as a drug based on claims like "Provides anti-inflammatory effects," and called several products misbranded. On January 3, 2020, the FDA closed it out, writing that "it appears that you have addressed the violations contained in this Warning Letter."
• BBB. Mannatech, Inc. had an A+ BBB rating and was "NOT a BBB Accredited Business" on the profile I read.

What Mannatech's Social Media Shows Right Now

These numbers were read from each public profile on October 14, 2026.

The YouTube channel hadn't posted in about four months when I checked.

The Good: What Mannatech Gets Right

• Transparency you can check. It's publicly traded, so its sales, debts and risks are in its SEC filings.
• A published income disclosure. It tells you how many Associates earned nothing.
• Cheap to join. $49.99, with no product purchase required to enroll.
• Problems addressed. The FDA closed out its 2017 warning letter in 2020.

The Concerns: What You Need to Know

• Going-concern doubt. The company's own report says there is "substantial doubt" about its ability to continue.
• Shrinking. 2025 sales fell to $108.0 million, and active positions fell to about 114,000.
• Most Associates earn nothing. 15,773 US Associates earned no commissions or bonuses in 2025.
• Premium prices. $159.99 for Ambrotose Complex.
• Legal history. The 2008 class action and 2009 Texas settlement are old, but worth knowing.

Product Alternatives

If you like the idea of these supplements but not the prices, here's what else is out there. These aren't the same formulas, I'm not making any health claim for them, and you should talk to your doctor before starting a supplement.

The Amazon prices are the buy-box prices on each listing when I checked on October 14, 2026, and all three were in stock. Prices change, so check before you buy.

Mannatech vs Other Supplement Companies

If you're comparing, read my Nu Skin review, another publicly traded direct seller, and my Plexus review, a gut-health supplement company. My Forever Living review covers a company that stopped recruiting in the US in 2026, and my 4Life review covers another immune-supplement company with a published income disclosure.

My Verdict: Is Mannatech Worth It in 2026?

One More Thing...

Mannatech's own numbers say most Associates don't earn. That's not because they didn't work. Most were taught to sell to friends and family, and that runs out fast.

There is a better way. When you share real, useful content about the products and the life you actually live, the right people come to you, and you never have to make a claim you can't back up. That works with any company.

That's what The Sponsoring System teaches. It's a free email series where I share the digital marketing that actually works for networkers. If you want it, start the free series here.

Frequently Asked Questions

Is Mannatech still in business?

Yes. Its US site was selling products with a 2026 copyright in October 2026, and it reported $26.7 million in net sales for the second quarter of 2026. Its own filings also say there is "substantial doubt" about its ability to continue as a going concern.

Is Mannatech an MLM?

Yes. Independent Associates pay $49.99 to join and earn through six bonus types in Mannatech's Career and Compensation Plan, including uni-level payouts on their team's sales.

How much do Mannatech Associates make?

Mannatech's 2025 US income disclosure says it had 17,989 US Associates at the end of 2025 and that 15,773 Associates "did not earn commissions or bonuses in 2025."

Has Mannatech had legal trouble?

Some, years ago. In 2008 it agreed to pay $11.25 million to settle a securities class action without admitting wrongdoing, and in 2009 it agreed to pay $6 million in a settlement with the Texas Attorney General that, the company said, "does not include any fine or penalty."

How much does Ambrotose cost?

On October 14, 2026, Mannatech's US site listed Ambrotose Complex powder at $159.99, with a retail price of $175.99.